Top

Graefe's Archive for Clinical and Experimental Ophthalmology

Published in:

01-11-2016 | Retinal Disorders

Circadian disturbance and idiopathic central serous chorioretinopathy

Authors: Elodie Setrouk, Beatrice Hubault, Frédérique Vankemmel, Olivia Zambrowski, Pierre Nazeyrollas, Brigitte Delemer, Vincent Durlach, Alain Ducasse, Carl Arndt

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 11/2016

Abstract

Background

This present retrospective case control study was designed to evaluate circadian disturbance in patients with chronic idiopathic central serous chorioretinopathy (ICSC).

Methods

Between January 1st, 2012, and November 30th, 2014, 29 consecutive patients with chronic ICSC examined in a referral setting were compared with a gender-matched and age-matched control group of 29 patients. A history of pharmacologic medication (including corticosteroid treatment), sleep disturbance, irregular working hours, cardiovascular risk factors, and depressive anxiety disorders was noted.

Results

The median age of the patients was 52, and in the control subjects it was 50. The male–female ratio for both groups was 4.8:1. Patients with chronic ISCS were more likely to be exposed to irregular working hours (p < 0.01, OR 9.3 [2.29–37.6]) and to present with overweight than the control subjects (p = 0.016). No significant differences were found for sleeping disturbances, pharmacological medication, cardiovascular risk factors, or depressive anxiety disorders.

Conclusions

In this preliminary study, the exposition of irregular working hours as a risk factor for chronic ICSC was identified, which had not been previously reported. If further studies confirm these findings, then employment with regular working hours could be recommended for chronic ICSC patients.

Spaide RF, Campeas L, Haas A et al (1996) Central serous chorioretinopathy in younger and older adults. Ophthalmology 103(12):2070–2080CrossRefPubMed

Klein ML, van Buskirk EM, Friedman E (1974) Experience with non-treatment of central serous choroidopathy. Arch Ophthalmol 91(4):247–250CrossRefPubMed

Loo RH, Scott IU, Flynn HW Jr et al (2002) Factors associated with reduced visual acuity during long-term follow-up patients with idiopathic central serous chorioretinopathy. Retina 22(1):19–24CrossRefPubMed

Gelber GS, Schatz H (1987) Loss of vision due to central serous chorioretinopathy following psychological stress. Am J Psychiatry 144(1):46–50CrossRefPubMed

Yannuzzi LA (1987) Type-A behavior and central serous chorioretinopathy. Retina 7(2):111–131CrossRefPubMed

Fastenberg DM, Ober RR (1983) Central serous choroidopathy in pregnancy. Arch Ophthalmol 101(7):1055–1058CrossRefPubMed

Gass JDM (1991) Central serous chorioretinopathy and white subretinal exudation during pregnancy. Arch Ophthalmol 109:677–681CrossRefPubMed

Friberg TR, Eller AW (1990) Serous retinal detachment resembling central serous chorioretinopathy following organ transplantation. Graefes Arch Clin Exp Ophthalmol 228:305–309CrossRefPubMed

Polak B, Baarsma G, Snyers B (1995) Diffuse retinal pigment epitheliopathy complicating systemic corticosteroid treatment. Br J Ophthalmol 79:922–925CrossRefPubMedPubMedCentral

10.

Gass JDM, Slamovits TL, Fuller DW, Gieser RG, Lean JS (1992) Posterior chorioretinopathy and retinal detachment after organ transplantation. Arch Ophthalmol 110:1717–1722CrossRefPubMed

11.

Matsuo T, Nakayama T, Koyama T, Matsuo N (1987) Multifocal pigment epithelial damages with serous retinal detachment in systemic lupus erythematosus. Ophthalmologica 195:97–102CrossRefPubMed

12.

Bouzas EA, Scott MH, Mastorakos S et al (1993) Central serous chorioretinopathy in endogenous hypercortisolism. Arch Ophthalmol 111:1229–1233CrossRefPubMed

13.

Jain IS, Singh K (1966) Maculopathy: a corticosteroid side-effect. J All India Ophthalmol Soc 14:250–252PubMed

14.

Haimovici R, Gragoudas ES, Duker JS, Sjaarda RN, Eliott D (1997) Central serous chorioretinopathy associated with inhaled or intranasal steroids. Ophthalmology 104:1653–1660CrossRefPubMed

15.

Arndt CF, Sari A, Ferre M et al (2001) Electrophysiological effects of corticosteroids on the retinal pigment epithelium. Invest Ophthalmol Vis Sci 42:472–475PubMed

16.

Tittl M, Spaide R, Wong D, Pilotto E, Yannuzzi L et al (1999) Systemic findings associated with central serous chorioretinopathy. Am J Ophthalmol 128(1):63–8CrossRefPubMed

17.

Ulhôa MA, Marqueze EC, Kantermann T, Skene D, Moreno C (2011) When does stress end? Evidence of a prolonged stress reaction in shiftworking truck drivers. Chronobiol Int 28(9):810–8CrossRefPubMed

18.

Harris A, Waage S, Ursin H, Eriksen HR (2011) Saliva cortisol levels in construction workers in the Arctic (78°N). Int J Circumpolar Health 70(5):542–51CrossRefPubMed

19.

Cutolo M, Buttgereit F, Straub RH (2011) Regulation of glucocorticoids by the central nervous system. Clin Exp Rheumatol 29(5 Suppl 68):S-19-22

20.

Williamson J, Nuki G (1970) Macular lesions during systemic therapy with depot tetracosactrin. Br J Ophthalmol 54:405–409CrossRefPubMedPubMedCentral

21.

Harada T, Harada K. Six (1985) cases of central serous chorioretinopathy induced by systemic corticosteroid therapy. Doc Ophthalmol 60:37–44

22.

Polak BC, Baarsma GS, Snyers B (1995) Diffuse retinal pigment epitheliopathy complicating systemic corticosteroid treatment. Br J Ophthalmol 79:922–925CrossRefPubMedPubMedCentral

23.

Yannuzzi LA (1986) Type A behavior and central serous chorioretinopathy. Trans Am Ophthalmol Soc 84:799–845PubMedPubMedCentral

24.

Michel V, Peinnequin A, Alonso A, Buguet A, Cespuglio R et al (2007) Decreased heat tolerance is associated with hypothalamo-pituitary-adrenocortical axis impairment. Neuroscience 147:522–31CrossRefPubMed

25.

Wright HE, Selkirk GA, McLellan TM (2010) HPA and SAS responses to increasing core temperature during uncompensable exertional heat stress in trained and untrained males. Eur J Appl Physiol 108:987–97CrossRefPubMed

26.

Schobitz B, Reul JM, Holsboer F (1994) The role of the hypothalamic-pituitary-adrenocortical system during inflammatory conditions. Crit Rev Neurobiol 8:263–91PubMed

27.

Mustafa S, Al-Bader MD, Elgazzar AH, Alshammeri J, Gopinath S et al (2008) Effect of hyperthermia on the function of thyroid gland. Eur J Appl Physiol 103:285–8CrossRefPubMed

28.

Sprague JE, Banks ML, Cook VJ, Mills EM (2003) Hypothalamic-pituitary-thyroid axis and sympathetic nervous system involvement in hyperthermia induced by 3,4 methylenedioxymethamphetamine (Ecstasy). J Pharmacol Exp Ther 305:159–66CrossRefPubMed

29.

Jung A, Schuppe HC (2007) Influence of genital heat stress on semen quality in humans. Andrologia 39:203–15CrossRefPubMed

30.

Khan VR, Brown IR (2002) The effect of hyperthermia on the induction of cell death in brain, testis, and thymus of the adult and developing rat. Cell Stress Chaperones 7:73–90CrossRefPubMedPubMedCentral

31.

Levay EA, Paolini AG, Govic A, Hazi A, Penman J et al (2010) HPA and sympathoadrenal activity of adult rats perinatally exposed to maternal mild calorie restriction. Behav Brain Res 208:202–8CrossRefPubMed

32.

Kilic E, Kilic U, Bacigaluppi M, Guo Z, Abdallah NB et al (2008) Delayed melatonin administration promotes neuronal survival, neurogenesis and motor recovery, and attenuates hyperactivity and anxiety after mild focal cerebral ischemia in mice. J Pineal Res 45:142–8CrossRefPubMed

33.

Belzung C, Griebel G (2001) Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav Brain Res 125:141–9CrossRefPubMed

34.

Paris JJ, Franco C, Sodano R, Freidenberg B, Gordis E et al (2010) Sex differences in salivary cortisol in response to acute stressors among healthy participants, in recreational or pathological gamblers, and in those with posttraumatic stress disorder. Horm Behav 57:35–45CrossRefPubMed

35.

Friedman M, Byers SO, Diamant J, Rosenman RH (1975) Plasma catecholamine response of coronary-prone subjects (type A) to a specific challenge. Metabolism 24:205–210CrossRefPubMed

36.

Williams RB Jr, Lane JD, Kuhn CM et al (1982) Type A behavior and elevated physiological and neuroendocrine responses to cognitive tasks. Science 218:483–485CrossRefPubMed

37.

Harbin TJ (1989) The relationship between the type A behavior pattern and physiological responsivity: a quantitative review. Psychophysiology 26:110–119CrossRefPubMed

38.

Kirschbaum C, Wust S, Hellhammer DH (1992) Consistent sex differences in cortisol responses to psychological stress. Psychosom Med 54:648–657CrossRefPubMed

39.

Yoshioka H, Sugita T, Nagayoski K (1970) Fluorescein angiography findings in experimental retinopathy produced by intravenous adrenaline injection. Folia Ophthalmol Jpn 21:648–652

40.

Nagayoski K (1971) Experimental study of chorioretinopathy by intravenous injection of adrenaline. Acta Soc Ophthalmol Jpn 75:1720–1727

41.

Miki T, Sunada I, Higaki T (1972) Studies on chorioretinitis induced in rabbits by stress (repeated administration of epinephrine). Acta Soc Ophthalmol Jpn 75:1037–1045

42.

Yoshioka H, Katsume Y, Akune H (1982) Experimental central serous chorioretinopathy in monkey eyes, II: fluorescein angiographic findings. Ophthalmologica 185:168–178CrossRefPubMed

43.

Lue YH, Hikim AP, Swerdloff RS, Im P, Taing KS et al (1999) Single exposure to heat induces stage-specific germ cell apoptosis in rats: role of intratesticular testosterone on stage specificity. Endocrinology 140:1709–17PubMed

44.

Wakakura M, Song E, Ishikawa S (1997) Corticosteroid-induced central serous chorioretinopathy. Jpn J Ophthalmol 41:180–185CrossRefPubMed

45.

Münch M, Linhart F, Borisuit A, Jaeggi SM, Scartezzini JL (1999) Effects of prior light exposure on early evening performance, subjective sleepiness, and hormonal secretion. Source Endocrinol 140:1709–17

46.

Skarlandtova H, Bicikova M, Neuzil P, Mlcek M, Hrachovina V et al (2012) Might cardiac catheterization influence diurnal rhythm of the steroid stress hormones secretion? Physiol Res 61:25–34PubMed

Title: Circadian disturbance and idiopathic central serous chorioretinopathy
Authors: Elodie Setrouk
Beatrice Hubault
Frédérique Vankemmel
Olivia Zambrowski
Pierre Nazeyrollas
Brigitte Delemer
Vincent Durlach
Alain Ducasse
Carl Arndt
Publication date: 01-11-2016
Publisher: Springer Berlin Heidelberg
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 11/2016
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-016-3378-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Circadian disturbance and idiopathic central serous chorioretinopathy

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 11/2016

Twelve-month outcomes of treatment using ranibizumab or aflibercept for neovascular age-related macular degeneration: a comparative study

Free ILM patch transplantation for recalcitrant macular holes; should we save some internal limiting membrane for later?

Role of RhoA/MERK1/ERK1/2/iNOS signaling in ocular ischemic syndrome

Intravitreal injection of methotrexate in persistent diabetic macular edema: a 6-month follow-up study

Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, Eighth Edition (2015) Eds: John E. Bennett, Raphael Dolin, Martin J. Blaser. ISBN: 13-978-1-4557-4801-3, Elsevier Saunders

Intraocular silicone implant to treat chronic ocular hypotony—preliminary feasibility data